Services
Glogger Consulting offers comprehensive advice on optimizing market access & pricing strategies for pharmaceuticals across EU—with a distinct focus on the German healthcare landscape. Glogger Consulting combines strategic insight and hands-on experience to support clients in navigating complex access environments and achieving sustainable reimbursement outcomes:
Glogger Consulting provides comprehensive strategic support across all phases of the HTA impacted phases from early clinical development to price negotiation and life cycle management. This is focused on German AMNOG and EU HTA processes including identification of potential challenges and development of solution-oriented strategies.
Clients benefit from guidance, strategic sparring to ensure thorough preparation as well as mock negotiations / hearings for authorities.
In the context of mergers, acquisitions, or portfolio evaluations, Glogger Consulting delivers rapid and high-impact analyses of pricing and reimbursement potential for pharmaceutical assets in the EU. These assessments are tailored to support strategic decision-making under tight timelines, offering an independent and expert external perspective. In addition extensive support for price negotations and reimbursement questions is part of this portfolio.
A strong and efficient market access & pricing team is key for success regardless of a large enterprise or a small biotech company.
Glogger consulting supports and develops optimal staffing concepts or optimizing the current structure for future success. Moreover, Glogger Consulting also helps in case of vacancies to support projects via a hands on approach.